CMH :: Clinical and Molecular Hepatology

Clinical and Molecular Hepatology Search

> Browse Articles > Search

Evaluation of bioenergetic and mitochondrial function in liver transplantation

Rui Miguel Martins, João Soeiro Teodoro, Emanuel Furtado, Anabela Pinto Rolo, Carlos Marques Palmeira, José Guilherme Tralhão

Clin Mol Hepatol.2019;25(2):190-198. Published online March 22, 2019
DOI: https://doi.org/10.3350/cmh.2018.0087

Endoscopic treatment or balloon-occluded retrograde transvenous obliteration is safe for patients with esophageal/gastric varices in Child-Pugh class C end-stage liver cirrhosis

Keiji Yokoyama, Ryo Yamauchi, Kumiko Shibata, Hiromi Fukuda, Hideo Kunimoto, Kazuhide Takata, Takashi Tanaka, Shinjiro Inomata, Daisuke Morihara, Yasuaki Takeyama, Satoshi Shakado, Shotaro Sakisaka

Clin Mol Hepatol.2019;25(2):183-189. Published online November 9, 2018
DOI: https://doi.org/10.3350/cmh.2018.0039

Cited By 1

Role of endoscopic treatment or balloon-occluded retrograde transvenous obliteration in patients with Child-Pugh class C end-stage liver cirrhosis and esophageal/gastric varices

Jin Wook Chung

Clin Mol Hepatol.2019;25(2):181-182. Published online December 21, 2018
DOI: https://doi.org/10.3350/cmh.2018.1010

Association between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B

Yun Bin Lee, Yeonjung Ha, Young Eun Chon, Mi Na Kim, Joo Ho Lee, Hana Park, Kwang-il Kim, Soo-Hwan Kim, Kyu Sung Rim, Seong Gyu Hwang

Clin Mol Hepatol.2019;25(1):52-64. Published online October 23, 2018
DOI: https://doi.org/10.3350/cmh.2018.0040

Cited By 2

Direct-acting antivirals-based therapy decreases hepatic fibrosis serum biomarker microfibrillar-associated protein 4 in hepatitis C patients

Christian Mölleken, Maike Ahrens, Anders Schlosser, Julia Dietz, Martin Eisenacher, Helmut E. Meyer, Wolff Schmiegel, Uffe Holmskov, Christoph Sarrazin, Grith Lykke Sorensen, Barbara Sitek, Thilo Bracht

Clin Mol Hepatol.2019;25(1):42-51. Published online November 19, 2018
DOI: https://doi.org/10.3350/cmh.2018.0029

Cited By 1

Pathologic differential diagnosis of metastatic carcinoma in the liver

Jeong Hwan Park, Jung Ho Kim

Clin Mol Hepatol.2019;25(1):12-20. Published online October 5, 2018
DOI: https://doi.org/10.3350/cmh.2018.0067

Recent research trends and updates on nonalcoholic fatty liver disease

Jeong-Ju Yoo, Won Kim, Moon Young Kim, Dae Won Jun, Sang Gyune Kim, Jong-Eun Yeon, Jin Woo Lee, Yong Kyun Cho, Sang Hoon Park, Joo Hyun Sohn, On behalf of the Korean Association for the Study of the Liver (KASL)-Korea Nonalcoholic fatty liver Study Group (KNSG)

Clin Mol Hepatol.2019;25(1):1-11. Published online August 8, 2018
DOI: https://doi.org/10.3350/cmh.2018.0037

Cited By 3

Favorable effect of corticosteroids in treating acute-on-chronic liver failure underlying chronic hepatitis B

Hyeji Kim, Jung Hyun Kwon, Yong Hee Kim, Soon Woo Nam, Jong Yul Lee, Jeong Won Jang

Clin Mol Hepatol.2018;24(4):430-435. Published online November 27, 2017
DOI: https://doi.org/10.3350/cmh.2017.0016

Bilateral optic neuropathy related to severe anemia in a patient with alcoholic cirrhosis: a case report and review of the literature

Lisa Humbertjean-Selton, Jérôme Selton, Nolwenn Riou-Comte, Jean-Christophe Lacour, Gioia Mione, Sébastien Richard

Clin Mol Hepatol.2018;24(4):417-423. Published online October 25, 2017
DOI: https://doi.org/10.3350/cmh.2017.0021

Cardiac diastolic dysfunction predicts poor prognosis in patients with decompensated liver cirrhosis

Soon Kyu Lee, Myeong Jun Song, Seok Hwan Kim, Hyo Jun Ahn

Clin Mol Hepatol.2018;24(4):409-416. Published online August 27, 2018
DOI: https://doi.org/10.3350/cmh.2018.0034

Cited By 2

Fatigue and weakness hinder patient social reintegration after liver transplantation

So Hyun Kang, YoungRok Choi, Ho-Seong Han, Yoo-Seok Yoon, Jai Young Cho, Sungho Kim, Kil Hwan Kim, In Gun Hyun, Ahmed Shehta

Clin Mol Hepatol.2018;24(4):402-408. Published online October 8, 2018
DOI: https://doi.org/10.3350/cmh.2018.0028

Cited By 1

The Association of leptin with severity of non-alcoholic fatty liver disease: A population-based study

Laura Rotundo, Alana Persaud, Mirela Feurdean, Sushil Ahlawat, Hyun-seok Kim

Clin Mol Hepatol.2018;24(4):392-401. Published online August 2, 2018
DOI: https://doi.org/10.3350/cmh.2018.0011

Cited By 2

Characterization and evaluation of liver fibrosis grade in patients with chronic hepatitis B virus infection and normal transaminases

San Juan López Cristina, Casado Martín Marta, González Sánchez Mercedes, Porcel Martín Almudena, Hernández Martínez Álvaro, Vega Sáenz Jose Luis, Parrón Carreño Tesifón

Clin Mol Hepatol.2018;24(4):384-391. Published online July 4, 2018
DOI: https://doi.org/10.3350/cmh.2018.0004

Cited By 2

Assessment of fibrotic burden among chronic hepatitis B virus-infected patients with normal transaminase level

Mi Young Jeon, Beom Kyung Kim, Seung Up Kim

Clin Mol Hepatol.2018;24(4):367-369. Published online September 19, 2018
DOI: https://doi.org/10.3350/cmh.2018.1008

Severe acute alcoholic hepatitis and liver transplant: A never-ending mournful story

Aiman Obed, Abdalla Bashir, Steffen Stern, Anwar Jarrad

Clin Mol Hepatol.2018;24(4):358-366. Published online October 24, 2018
DOI: https://doi.org/10.3350/cmh.2018.0044

Combined effects of synbiotic and sitagliptin versus sitagliptin alone in patients with nonalcoholic fatty liver disease

Saba Sayari, Hassan Neishaboori, Maryam Jameshorani

Clin Mol Hepatol.2018;24(3):331-338. Published online June 12, 2018
DOI: https://doi.org/10.3350/cmh.2018.0006

Cited By 6

Combination of synbiotic and sitagliptin in nonalcoholic fatty liver disease: Is it better than sitagliptin alone?

Yong Kyun Cho

Clin Mol Hepatol.2018;24(3):299-301. Published online September 7, 2018
DOI: https://doi.org/10.3350/cmh.2018.1006

Recent update of the 2017 Korean Association for the Study of the Liver (KASL) treatment guidelines of chronic hepatitis C: Comparison of guidelines from other continents, 2017 AASLD/IDSA and 2016 EASL

Jong Eun Yeon

Clin Mol Hepatol.2018;24(3):278-293. Published online May 2, 2018
DOI: https://doi.org/10.3350/cmh.2018.1002

Living-donor liver transplantation for giant hepatic hemangioma with diffuse hemangiomatosis in an adult: a case report

Ju Hyun Lee, Chang Jin Yoon, Young Hoon Kim, Ho-Seong Han, Jai Young Cho, Haeryoung Kim, Eun Sun Jang, Jin-Wook Kim, Sook-Hyang Jeong

Clin Mol Hepatol.2018;24(2):163-168. Published online July 19, 2017
DOI: https://doi.org/10.3350/cmh.2017.0002

Cited By 1

Management of chronic hepatitis B patients in immunetolerant phase: what latest guidelines recommend

Grace Lai-Hung Wong

Clin Mol Hepatol.2018;24(2):108-113. Published online January 22, 2018
DOI: https://doi.org/10.3350/cmh.2017.0068

Cited By 5

Microbiota, a key player in alcoholic liver disease

Anne-Marie Cassard, Dragos Ciocan

Clin Mol Hepatol.2018;24(2):100-107. Published online December 22, 2017
DOI: https://doi.org/10.3350/cmh.2017.0067

Cited By 12

Epidemiology of alcoholic liver disease in Korea

Jae Young Jang, Dong Joon Kim

Clin Mol Hepatol.2018;24(2):93-99. Published online March 16, 2018
DOI: https://doi.org/10.3350/cmh.2017.0079

Cited By 3

Metastatic endophthalmitis and thyroid abscess complicating Klebsiella pneumoniae liver abscess

Seon-Jae Kim, Seong Taek Chu, Keun Sook Lee, Seung Woo Nam, Jong Kyoung Choi, Joo Won Chung, Hyeok Choon Kwon

Clin Mol Hepatol.2018;24(1):88-91. Published online June 28, 2017
DOI: https://doi.org/10.3350/cmh.2016.0066

Picroside II attenuates fatty acid accumulation in HepG2 cells via modulation of fatty acid uptake and synthesis

Hiteshi Dhami-Shah, Rama Vaidya, Shobha Udipi, Srividhya Raghavan, Shiny Abhijit, Viswanathan Mohan, Muthuswamy Balasubramanyam, Ashok Vaidya

Clin Mol Hepatol.2018;24(1):77-87. Published online December 19, 2017
DOI: https://doi.org/10.3350/cmh.2017.0039

Cited By 1

Serum matrix metalloproteinase-1 level represents disease activity as opposed to fibrosis in patients with histologically proven nonalcoholic steatohepatitis

Wataru Ando, Hiroaki Yokomori, Nobuhiro Tsutsui, Eigoro Yamanouchi, Yutaka Suzuki, Masaya Oda, Yutaka Inagaki, Katsuya Otori, Isao Okazaki

Clin Mol Hepatol.2018;24(1):61-76. Published online November 20, 2017
DOI: https://doi.org/10.3350/cmh.2017.0030

Cited By 2

Resection plane-dependent error in computed tomography volumetry of the right hepatic lobe in living liver donors

Heon-Ju Kwon, Kyoung Won Kim, Bohyun Kim, So Yeon Kim, Chul Seung Lee, Jeongjin Lee, Gi Won Song, Sung Gyu Lee

Clin Mol Hepatol.2018;24(1):54-60. Published online August 1, 2017
DOI: https://doi.org/10.3350/cmh.2017.0023

Cited By 4

Clinical implication of hepatic volumetry for living donor liver transplantation

Woo Kyoung Jeong

Clin Mol Hepatol.2018;24(1):51-53. Published online March 22, 2018
DOI: https://doi.org/10.3350/cmh.2018.1003

Role of liver transplantation in severe alcoholic hepatitis

Ravi Daswani, Ashish Kumar, Praveen Sharma, Vikas Singla, Naresh Bansal, Anil Arora

Clin Mol Hepatol.2018;24(1):43-50. Published online January 10, 2018
DOI: https://doi.org/10.3350/cmh.2017.0027

Cited By 3

Current epidemiology and clinical characteristics of autoimmune liver diseases in South Korea

Sook-Hyang Jeong

Clin Mol Hepatol.2018;24(1):10-19. Published online January 5, 2018
DOI: https://doi.org/10.3350/cmh.2017.0066

Cited By 3

Epidemiology of liver cancer in South Korea

Bo Hyun Kim, Joong-Won Park

Clin Mol Hepatol.2018;24(1):1-9. Published online December 18, 2017
DOI: https://doi.org/10.3350/cmh.2017.0112

Cited By 18

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next

The Korean Association for the Study of the Liver